Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × entinostat × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 3 Neoplasm Metastasis 2 Melanoma 2 Carcinoma, Renal Cell 2 Urinary Bladder Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1 Lymphoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Brain Stem Neoplasms 1 Brain Neoplasms 1

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡